NCT00216736View on ClinicalTrials.gov

Oral Dexamethasone for Treatment of Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

July 31, 2007

Conditions
Migraine
Interventions
DRUG

Dexamethasone

Single dose oral dexamethasone 8mg at time of ED discharge

DRUG

placebo

Single dose oral placebo at ED discharge

Trial Locations (1)

3011

Department of Emergency Medicine, Western Health, Melbourne

All Listed Sponsors
lead

The Joseph Epstein Centre for Emergency Medicine Research

OTHER

NCT00216736 - Oral Dexamethasone for Treatment of Migraine | Biotech Hunter | Biotech Hunter